Clinical Trial Update: Circadian Mechanisms, Glucose, and CV Risks in T1D [NA]

View source ↗

Summary

A University of Illinois at Chicago-sponsored clinical trial is examining circadian mechanisms, glucose regulation, and cardiovascular risk in Type 1 diabetes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Type 1 Diabetes (T1D) | NA | Status: RECRUITING